Steady hands at the helm: John Corbett to guide DMC into next chapter

As DMC prepares for the critical step of entering clinical trials, we have appointed John Corbett as Interim CEO. John brings considerable business acumen and strategic skills to the role, having served as our CFO for 5 years. John will be working closely with the DMC Board in updating our strategy and identifying options ahead of a very busy execution focus in 2026.

John’s career has spanned both the fastmoving world of technology start-ups and the structured discipline and demand of large institutions. With more than 20 years’ experience in corporate banking – including senior roles at ANZ and Suncorp – John has developed a strong instinct for rigorous risk management and financial oversight, coupled with his past exposure as banker to some of Australia’s most successful entrepreneurs.

His subsequent work in investment and funds management, notably as a founding director of Hassad Australia, a $600 million agricultural enterprise owned by the Qatar Investment Authority, and as Senior Investment Director at Argyle Capital Partners, adds another important layer of commercial expertise.

John has a strong reputation for developing effective pathways through financial and business complexities. What excites him about stepping into the role of CEO is the opportunity to sit at the intersection of science, innovation and commerce.

“It’s not often you get the chance to be part of something that has the potential to achieve strong commercial outcomes while also transforming lives,” he reflects.

“From here, we’ll be focused on ensuring that De Motu Cordis can balance its innovative spirit with the discipline of robust governance and sustainable strategy which will be key to unlocking that potential.”